Remove 2021 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. One case of drug contamination from 2021 was highlighted in the paper. Ahmed et al. Ahmed et al.

article thumbnail

Utilising content metrics to improve digital engagement

pharmaphorum

The 2021 Veeva Pulse Content Metrics Report provides information on how current digital trends impact the commercial content landscape and how Veeva utilises these trends to improve brand engagement. Digital content can then be approved quicker without jeopardising content compliant delivery.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Tablets were noted to be the most common form of OSD in 2021 because of their convenience and simplicity in production, transportation and delivery to the end user. This is especially beneficial as a way of decreasing potential side effects.

Dosage 98
article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. This will result in permanent shifts in how HCPs and patients interact with pharmaceutical companies.

article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports. Or you may want to take stock of your life. Well, whatever you do, have a grand time.

FDA 97
article thumbnail

The osteoarthritis market is expected to increase to $3.8bn in 2031

Pharmaceutical Technology

billion in the 7MM (seven major markets) in 2021, and is expected to increase to $3.8 billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. The OA space has long been dominated by large pharmaceutical companies such as Bayer, Pfizer, and Eli Lilly. The osteoarthritis (OA) market was valued at $2.5

article thumbnail

Innovation in small molecules: Leading companies in quinoline derivatives as anticancer agents

Pharmaceutical Technology

According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The structure of quinoline is represented by the fusion of benzene ring with pyridine at two neighbouring carbon atoms.